1. Home
  2. KMDA vs FOF Comparison

KMDA vs FOF Comparison

Compare KMDA & FOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KMDA
  • FOF
  • Stock Information
  • Founded
  • KMDA 1990
  • FOF 2006
  • Country
  • KMDA Israel
  • FOF United States
  • Employees
  • KMDA N/A
  • FOF N/A
  • Industry
  • KMDA Biotechnology: Pharmaceutical Preparations
  • FOF Investment Managers
  • Sector
  • KMDA Health Care
  • FOF Finance
  • Exchange
  • KMDA Nasdaq
  • FOF Nasdaq
  • Market Cap
  • KMDA 310.1M
  • FOF 357.1M
  • IPO Year
  • KMDA N/A
  • FOF N/A
  • Fundamental
  • Price
  • KMDA $5.97
  • FOF $13.20
  • Analyst Decision
  • KMDA Strong Buy
  • FOF
  • Analyst Count
  • KMDA 2
  • FOF 0
  • Target Price
  • KMDA $14.50
  • FOF N/A
  • AVG Volume (30 Days)
  • KMDA 40.9K
  • FOF 58.7K
  • Earning Date
  • KMDA 11-13-2024
  • FOF 01-01-0001
  • Dividend Yield
  • KMDA N/A
  • FOF 9.07%
  • EPS Growth
  • KMDA 230.67
  • FOF N/A
  • EPS
  • KMDA 0.25
  • FOF N/A
  • Revenue
  • KMDA $154,574,000.00
  • FOF N/A
  • Revenue This Year
  • KMDA $14.85
  • FOF N/A
  • Revenue Next Year
  • KMDA $7.64
  • FOF N/A
  • P/E Ratio
  • KMDA $22.94
  • FOF N/A
  • Revenue Growth
  • KMDA 6.01
  • FOF N/A
  • 52 Week Low
  • KMDA $4.58
  • FOF $9.59
  • 52 Week High
  • KMDA $6.53
  • FOF $11.75
  • Technical
  • Relative Strength Index (RSI)
  • KMDA 77.16
  • FOF 59.85
  • Support Level
  • KMDA $5.84
  • FOF $12.60
  • Resistance Level
  • KMDA $6.06
  • FOF $13.17
  • Average True Range (ATR)
  • KMDA 0.12
  • FOF 0.18
  • MACD
  • KMDA 0.07
  • FOF 0.01
  • Stochastic Oscillator
  • KMDA 91.57
  • FOF 91.23

About KMDA Kamada Ltd.

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

About FOF Cohen & Steers Closed-End Opportunity Fund Inc.

Cohen & Steers Closed-end Opp Fd Inc is a diversified, closed-ended management investment company. Its investment objective is to achieve a total return, consisting of high current income and potential capital appreciation.

Share on Social Networks: